1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2024Association between obesity and cancer risk in adults with HIV in Korea AIDS
2024Nationwide Analysis of Antimicrobial Prescription in Korean Hospitals between 2018 and 2021: The 2023 KONAS Report INFECTION AND CHEMOTHERAPY
2024Variation in immunoglobulin use and impact on survival in myeloma EJHAEM
2024A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer FUTURE ONCOLOGY
2024Impact of proton pump inhibitor use on clinical outcomes in East Asian patients receiving clopidogrel following drug-eluting stent implantation BMC MEDICINE
2024Comparison of Statin With Ezetimibe Combination Therapy Versus Statin Monotherapy for Primary Prevention in Middle-Aged Adults KOREAN CIRCULATION JOURNAL
2024T-Cell Dynamics Predicts Prognosis of Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2024Foritinib, a type II ROS1 inhibitor for NSCLCLANCET RESPIRATORY MEDICINE
2024Can DAPT be discontinued at one month after PCI in high bleeding risk patients presenting with ACS? EUROINTERVENTION
2024A multisociety Delphi consensus statement on new fatty liver disease nomenclature ANNALS OF HEPATOLOGY(Annals of Hepatology)
2024Lean individuals with nonalcoholic fatty liver disease, the chicken or the egg? HEPATOBILIARY SURGERY AND NUTRITION
2024Исследование III фазы CLEAR у пациентов с распространенным почечно-клеточным раком: анализ в подгруппах больных, получавших ленватиниб с пембролизумабом и сунитиниб ONKOUROLOGIYA
2024Translational Research in ROS1-Positive NSCLC: Are We Moving Out of the Six Blind Men and the Elephant Stage? JOURNAL OF THORACIC ONCOLOGY
2024Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial ESMO OPEN
2024Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B CANCER
2024ATTLAS, IMpower151 and ORIENT-31: Dusting off IMpower150 for Post-Osimertinib in EGFR-Mutated NSCLC? Lung Cancer : targets and therapy
2024Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey Lung Cancer : targets and therapy
2024Embolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomes CARDIOVASCULAR REVASCULARIZATION MEDICINE
2024Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis JHEP REPORTS
2024Trends and socioeconomic inequality of the burden of congenital abnormalities of the kidney and urinary tract among children and adolescentsNEPHROLOGY DIALYSIS TRANSPLANTATION

Recent Submissions

Browse

Links